News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 1421
- Sources here
- 19
- Companies here
- 18
Active search
1421 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
CVD Equipment (NASDAQ: CVV) posts Q2 2026 profit but core revenue drops 42.6%
CVD Equipment Corporation reported a net profit of $12.6 million for Q2 2026, primarily due to a $13.9 million gain from the sale of its SDC division for $17.4 million. This transaction significantly boosted the company's cash reserves to $23.5 million and eliminated long-term …
CVD Equipment (CVV) posts Q2 profit on SDC sale amid sharp revenue drop
CVD Equipment Corporation reported a Q2 2026 profit of $12.57 million, or $1.81 per share, primarily driven by a $13.5 million net gain from the sale of its SDC business. This profit occurred despite a significant 42.6% drop in revenue from continuing operations, which …
EquipmentShare.com Stock Drop – If You Incurred Significant Losses Investing in EQPT Contact Robbins LLP for Information About Leading the Securities Class Action
Robbins LLP has filed a securities class action lawsuit against EquipmentShare.com, Inc. (NASDAQ: EQPT) on behalf of investors who incurred losses from the company's January 2026 IPO and subsequent stock purchases between January 23 and June 23, 2026. The lawsuit alleges that EquipmentShare made …
Xilio Therapeutics (NASDAQ:XLO) Announces Earnings Results, Beats Estimates By $0.26 EPS
Xilio Therapeutics (NASDAQ:XLO) announced its earnings results, reporting an adjusted loss of $0.33 per share, which beat analyst estimates by $0.26. The company's revenue of $18.69 million also surpassed expectations, though Xilio Therapeutics remains unprofitable with a negative net margin. Despite institutional investor ownership …
Xilio Therapeutics Releases Q2 2026 Financial Results
Xilio Therapeutics (XLO) reported its Q2 2026 financial results, showing a narrower net loss of $0.33 per share, an 85.3% improvement year-over-year. Revenue significantly increased by 131.2% to $18.7 million compared to Q2 2025. The company specializes in tumor-activated immuno-oncology therapies and continues to …
Goldman Sachs Group (TDAC) discloses 1,056,879 TDAC shares in 7.2% stake
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 1,056,879 Class A ordinary shares in Translational Development Acquisition Corp. (TDAC), representing a 7.2% stake. Both entities hold shared voting and shared dispositive power over …
REG - Trainline PLC JPMorgan Chase & Co - Holding(s) in Company
JPMorgan Chase & Co. has notified Trainline PLC of a change in its major holdings, crossing a threshold on August 10, 2026, and notifying the issuer on August 12, 2026. The financial institution now holds a total of 5.143391% of voting rights, combining direct …
JPMorgan Stock Rises 0.7% as Bank Calls for S&P 8,000
This article first appeared on GuruFocus. JPMorgan Chase (NYSE:JPM), America's largest bank by assets, rose approximately 0.7% Wednesday morning as its strategy team turned even more bullish on stocks. The bank now sees the S&P 500 (SPY) ending 2026 at 8,000, up from its …
Sharemaestro market context Trend signal active 52 weeks +12.3% · Next-week setup positive 61.6%DeFi Development Corp. Reports Q2 2026 Results, Grows SOL
DeFi Development Corp. (Nasdaq: DFDV) announced its Q2 2026 results, highlighting a 24% year-over-year growth in SOL per share (SPS) to 0.066 and a total of 2,311,523 SOL and equivalents. The company outlined Q3 cost efficiencies, capital structure simplification, and reaffirmed its long-term target …
JPMorgan Chase (JPM) reports 34,064 positions in latest Form 13F
JPMorgan Chase has filed its latest Form 13F holdings report, disclosing 34,064 individual reportable positions with an aggregate value exceeding $1.8 trillion. The filing, signed by Executive Director Michael T. Lees, indicates a full holdings report and includes 17 other affiliated managers within the …
Sharemaestro market context Trend signal active 52 weeks +12.3% · Next-week setup positive 61.6%Transcript : Peyto Exploration & Development Corp., Q2 2026 Earnings Call, Aug 12, 2026
Key Points Interested in Peyto Exploration & Development Corp.? Here are five stocks we like better. Q2 financial performance remained solid: Peyto generated C$228 million in funds from operations, reduced net debt by C$72 million and raised its monthly dividend by 9%, despite seasonal …
JPMorgan Sees S&P 500 at 8,000: ETFs That Are Worth Buying
A stronger earnings outlook and the potential for AI spending by major hyperscalers to accelerate revenue growth have led J.P. Morgan JPM to raise its year-end S&P 500 target to 8,000 from 7,800 previously. As quoted on Reuters, the Wall Street giant's latest 8,000 …
JPMorgan Chase (JPM) Stock Gets Fair Value Boost After Analysts Raise Targets
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. JPMorgan Chase is back in focus after analysts lifted their fair value estimate from about US$353.95 to roughly US$373.86 per share, pointing to a higher …
Scott Bessent says America’s Founding Fathers ‘could not have imagined’ today’s economy — how to bet big on the USA
Magnus Lejhall/ Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. 250 years after America declared its independence, Treasury Secretary Scott Bessent says the economic experiment launched by the country's Founding Fathers has grown into …
EQUIPMENTSHARE.COM, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 21, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
Bernstein Liebhard LLP reminds investors of EquipmentShare.com, Inc. (NASDAQ: EQPT) about the September 21, 2026 deadline to join a securities fraud class action lawsuit. The lawsuit alleges that EquipmentShare made materially false and misleading statements regarding its business, leading to inflated stock prices and …
Form 8K Xilio Therapeutics Inc For: 12 August By Investing.com
This article reports on Xilio Therapeutics Inc.'s Form 8K filing for August 12. It notes the company's stock symbol as XLO, which saw a -1.42% change. The content primarily serves as a placeholder or announcement regarding the SEC filing.
Xilio Therapeutics reports Q2 2026: $18.7M collaboration revenue, $6.4M net loss, cash $136.0M
Xilio Therapeutics reported its Q2 2026 financial results, showing $18.7 million in collaboration revenue and a net loss of $6.4 million. The company held $136.0 million in cash and cash equivalents, expecting this to fund operations into Q1 2028. Key business highlights include FDA …
Xilio expects to dose cancer patients with XTX501 in H2 2026
Xilio Therapeutics reported its Q2 2026 financial results and provided updates on its pipeline, including FDA clearance for XTX501, a bispecific PD-1 / masked IL-2, with dosing expected in H2 2026. The company also announced advancing IND-enabling studies for two masked T cell engager …
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
JPMorgan Asset Management (Canada) Inc. TORONTO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- J. P. Morgan Asset Management (JPMAM)* today announced the final July 2026 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of …
ChipMOS stock (IMOS) climbs 12% after revenue hits record and margin jumps 11.4 points
ChipMOS (IMOS) shares surged 11.7% after the company reported its highest quarterly revenue since 2014 and a significant rebound in gross margin to 18.0%, up from 6.6% year-over-year. Demand for memory products, especially DRAM, and increased pricing for services contributed to the strong performance. …
Chase Bank Is Closing Another Wave of Branches This Summer: See a List of Shuttered Locations in Several States
Chase Bank, the largest U.S. retail banking network, continues to invest in physical branches, having opened over 1,000 locations since 2018. However, its net branch count has not significantly increased due to the simultaneous closure of branches deemed unnecessary. This summer, over a dozen …